Q4 2024 · 13F-HR
Finepoint Capital LPholdings as filed
Filed 2025-02-13 · accession 0000904454-25-000119
$1.64B
Reported value
26
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $442.5M | 27.0% | 755,000 | PUT | SOLE |
| 82846H405 | QXO | QXO INC | $396.4M | 24.2% | 24,933,825 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $328.1M | 20.0% | 1,485,000 | PUT | SOLE |
| 530307305 | LBRDK | Liberty Broadband Corp | $150.7M | 9.20% | 2,015,710 | Common | SOLE |
| 531229722 | LLYVK* | LIBERTY MEDIA CORP DEL | $55.3M | 3.38% | 812,792 | Common | SOLE |
| 04016X101 | ARGX | Argenx SE | $32.6M | 1.99% | 52,928 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $31.1M | 1.90% | 710,260 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $27.1M | 1.65% | 748,752 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $25.5M | 1.55% | 184,872 | Common | SOLE |
| 61559X104 | MLTX | MoonLake Immunotherapeutics | $24.3M | 1.48% | 447,935 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $19.7M | 1.20% | 161,935 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $18.6M | 1.13% | 674,762 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $15.2M | 0.93% | 660,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $15.0M | 0.91% | 318,448 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $13.7M | 0.84% | 713,778 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $11.4M | 0.69% | 391,300 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $9.1M | 0.56% | 657,071 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $9.0M | 0.55% | 2,175,646 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $8.3M | 0.51% | 1,111,104 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $3.8M | 0.23% | 961,251 | Common | SOLE |
| 01444V103 | ANNA | ALEANNA INC | $196,791 | 0.01% | 27,717 | Common | SOLE |
| 01444V111 | ANNAW | ALEANNA INC | $68,600 | 0.00% | 490,000 | Common | SOLE |
| G6202B119 | MNYWW | MONEYHERO LIMITED | $49,404 | 0.00% | 895,000 | Common | SOLE |
| G9845F117 | LSBWF | LAKESHORE BIOPHARMA CO LTD | $48,510 | 0.00% | 489,999 | Common | SOLE |
| 56608A113 | — | Marblegate Acquisition Corp | $25,652 | 0.00% | 735,000 | Common | SOLE |
| 320703309 | — | CALIDI BIOTHERAPEUTICS INC | $14,375 | 0.00% | 12,500 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.